That, according to one of Wall Street’s most influential investors, Dawn Fitzpatrick, CEO of Soros Fund Management. She told ...

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks - Nation and World News | Hawaii Tribune-Herald ...

Three individuals, along with the group accused of supplying the peptides, were fined between $5,000 and $10,000 for their ...

Lido unveils EarnUSD vault for stablecoin yields on USDC and USDT, alongside revamped ETH strategies, making DeFi returns more accessible.

Compounding pharmacies are illegally selling GLP-1 drugs, and the FDA is determined to shut that pathway down.

Medical groups affiliated with telehealth companies the FDA warned about marketing of compounded weight loss drugs may be under the microscope, too ...

Q4 2025 Earnings Call March 12, 2026 1:00 PM EDTCompany ParticipantsCraig Armitage - Investor Relations OfficerDavid Feller ...

This data really does show that buying a home can be an accelerator for your net worth,” explains Hannah Jones, Realtor.com senior economic research analyst.

She found plenty of options and settled on a cheaper, imitation version of the name-brand drugs for $177 a month that she could buy without going through insurance. “It’s absolutely odd,” she said of ...

Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. | Eli Lilly—which has already staged multiple efforts in ...

Combining tirzepatide with vitamin B12, a common additive in compounded versions of the drug, yields an impurity that could ...